Analyst Ratings for ADMA Biologics (ADMA)
ADMA Rating Summary
ADMA Price Target Summary
- Highest: $21.00 (Raymond James)
- Lowest: $18.00 (Canaccord)
- Average: $19.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$19.67 (+136.7%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
Avg. $ Target:
$19.67 (+136.7%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | Raymond James | Ryan Deschner | New Coverage | Outperform (N/A) |
21.00 (N/A) |
8.12 (8.31) |
2.34% | Details |
| 4/20/2026 | Canaccord » Updated 5/7/2026 |
Gary Nachmann | New Coverage | Buy (N/A) |
18.00 (21.00) |
11.01 (8.31) |
-24.52% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
